GlobalData Archives - Page 7 of 41 - Express Pharma

MASH innovator drug partnerships surge over $2.5 bn in 2024YTD: GlobalData

Basilea’s Zevtera will play unique yet critical role in MRSAB: GlobalData

CRISPR-based innovations drive $21 bn in pharma licensing deals over five years: GlobalData

Generics gain ground, yet HCPs still favor branded drugs: GlobalData

Active cooperation among APAC pharma companies gaining traction: GlobalData

Vaccines in late-stage development hold promise in tackling disease burden: GlobalData

Pfizer’s Braftovi to command 42 per cent share of BRAF inhibitors melanoma market by 2028: GlobalData

GLP1 agonists set to become the best-selling drugs in 2024: GlobalData

Biomarkers becoming important for approval of ALS therapies: GlobalData

Biotech funding set for recovery in 2024: GlobalData